Are you Dr. Jotwani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
Rm M987
San Francisco, CA 94143Phone+1 415-476-1528
Summary
- Dr. Vasantha Jotwani, MD is a nephrologist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Medical Center, Zuckerberg San Francisco General Hospital and Trauma Center, and San Francisco VA Medical Center.
Education & Training
- University of California (San Francisco)Fellowship, Nephrology, 2012 - 2014
- University of California (San Francisco)Residency, Internal Medicine, 2008 - 2012
- Northwestern University The Feinberg School of MedicineClass of 2008
Certifications & Licensure
- CA State Medical License 2010 - 2026
Publications & Presentations
PubMed
- 244 citationsThe case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Confer...Michael G. Shlipak, Sri Lekha Tummalapalli, L. Ebony Boulware, Morgan E. Grams, Joachim H. Ix
Kidney International. 2021-01-01 - 46 citationsMarkers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trialPranav S. Garimella, Alexandra K. Lee, Walter T. Ambrosius, Udayan Bhatt, Alfred K. Cheung
European Heart Journal. 2019-11-01 - 32 citationsUrinary Markers of Fibrosis and Risk of Cardiovascular Events and Death in Kidney Transplant Recipients: The FAVORIT Trial.Meyeon Park, Ronit Katz, Michael G. Shlipak, Daniel E. Weiner, Russel Tracy
American Journal of Transplantation. 2017-04-26
Authored Content
- Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in EldersMarch 2018
- Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in EldersMarch 2018